Assignee
SPARX BIOSCIENCE LTD
VG·2 granted patents·4 pending applications·0 citations·filing 2021–2025
Top patents by PatentIndex Score
6 records- 0162US12460005B2Binding molecules specific for claudin 18.2, compositions and methods thereof, for treatment of cancer and other diseasesSPARX BIOSCIENCE LTD·Filed 2022·Granted Nov 4, 2025·0 cites·10 claims
- 0255US2023034659A1Anti-pdl1 antibodies and uses thereofSPARX BIOSCIENCE LTD·Filed 2022·Application pending·0 cites
- 0355US2024287189A1Anti-pdl1 antibodies and uses thereofSPARX BIOSCIENCE LTD·Filed 2022·Application pending·0 cites
- 0455US2024109962A1Antibodies binding to leukocyte immunoglobulin-like receptor subfamily b member 2 (lilrb2) and uses thereofSPARX BIOSCIENCE LTD·Filed 2023·Application pending·0 cites
- 0550US2026027222A1Peptide linkers for construction and reducing aggregation of fusion polypeptides comprising suchSPARX BIOSCIENCE LTD·Filed 2025·Application pending·0 cites
- 0645US11970533B2Bispecific antibodies targeting human claudin 18.2 and programmed death-ligand 1 (PD-L1)SPARX BIOSCIENCE LTD·Filed 2021·Granted Apr 30, 2024·0 cites·30 claims
Join the waitlist — get patent alerts
Get an alert when SPARX BIOSCIENCE LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →